Journey Medical (DERM) Consolidated Net Income (2020 - 2026)
Journey Medical's (DERM) quarterly Consolidated Net Income came in at -$2.2 million in Q1 2026, up 45.25% YoY from -$1.5 million in Q1 2025, and down 81.45% on a QoQ basis from -$1.2 million in Q4 2025.
Journey Medical (DERM) Consolidated Net Income (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Consolidated Net Income data on file, last reported at -$2.2 million in Q1 2026.
- Quarterly Consolidated Net Income rose 45.25% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.6 million (down 16.11% YoY) and the FY2025 annual result came in at -$11.4 million, up 22.21% from the prior year.
- Consolidated Net Income retreated to -$2.2 million in Q1 2026, from -$1.2 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $16.8 million in Q3 2023 to a low of -$10.6 million in Q4 2022.
- A 5-year average of -$3.6 million and a median of -$3.4 million in 2024 frame the typical range for Consolidated Net Income.
- The widest YoY moves for Consolidated Net Income: up 266.56% in 2023, down 635.56% in 2023.
- Tracing DERM's Consolidated Net Income over 5 years: stood at -$10.6 million in 2022, then jumped by 79.86% to -$2.1 million in 2023, then jumped by 173.82% to $1.6 million in 2024, then slumped by 177.69% to -$1.2 million in 2025, then slumped by 81.45% to -$2.2 million in 2026.
- The last three Consolidated Net Income figures came in at -$2.2 million (Q1 2026), -$1.2 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.65 Mn | 180.01 Mn | 12.37 Mn | -312,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -312,000.00 |
| Mar 31, 2026 | -2.23 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | -2.32 Mn |
| Jun 30, 2025 | -3.80 Mn |
| Mar 31, 2025 | -4.07 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | -2.39 Mn |
| Jun 30, 2024 | -3.36 Mn |
| Mar 31, 2024 | -10.44 Mn |
| Dec 31, 2023 | -2.14 Mn |
| Sep 30, 2023 | 16.79 Mn |
| Jun 30, 2023 | -8.36 Mn |
| Mar 31, 2023 | -10.14 Mn |
| Dec 31, 2022 | -10.64 Mn |
| Sep 30, 2022 | -10.08 Mn |
| Jun 30, 2022 | -7.53 Mn |
| Mar 31, 2022 | -1.38 Mn |
| Dec 31, 2021 | -21.75 Mn |
| Sep 30, 2021 | -10.65 Mn |